Daniell Richard — SEC insider filings
SEC reporting owner CIK 1726096. 28 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2020-09-10 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 41 legs across 23 filings — 1,272,417 shares, $25,306,656 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 80.
- Largest priced transaction: sale of 115,468 shares @ $28.68 ($3,311,126) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2025-12-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | 28 | — | 41 legs · 1,272,417 sh · $25,306,656 | 80 |
Insider filings — Daniell Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 25,000 @ $34.70 · Sale (S): 25,000 @ $42.91 · Option exercise (M): 20,003 @ $34.70 · Sale (S): 20,003 @ $42.80 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 20,003 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 30,000 @ $35.40 | EDGAR |
| 2026-03-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 17,295 · Sale (S): 17,295 @ $31.67 · Option exercise (M): 17,295 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Sale (S): 33,512 @ $32.46 · Option exercise (M): 20,461 · Sale (S): 20,461 @ $32.46 · Sale (S): 37,372 @ $32.95 · Option exercise (M): 33,512 (derivative) @ $0 · +2 more | EDGAR |
| 2026-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 62,250 · Sale (S): 62,250 @ $32.36 · Option exercise (M): 141,478 · Sale (S): 66,735 @ $32.36 · Option exercise (M): 62,250 (derivative) @ $0 · Option exercise (M): 141,478 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 141,478 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 100,457 @ $18.61 · Option exercise (M): 15,011 @ $16.99 · Sale (S): 115,468 @ $28.68 · Option exercise (M): 100,457 (derivative) @ $0 · Option exercise (M): 15,011 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 22,576 · Sale (S): 22,576 @ $15.91 · Sale (S): 48,385 @ $15.90 · Option exercise (M): 22,576 (derivative) @ $0 · Grant/award (A): 69,182 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Sale (S): 21,870 @ $15.73 · Sale (S): 11,641 @ $15.91 · Option exercise (M): 20,461 · Sale (S): 13,353 @ $15.73 · Sale (S): 7,108 @ $15.91 · +6 more | EDGAR |
| 2025-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 62,250 · Sale (S): 49,314 @ $16.19 · Sale (S): 12,936 @ $15.56 · Option exercise (M): 62,250 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 183,169 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 98,943 @ $17.30 | EDGAR |
| 2024-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 22,576 · Sale (S): 22,576 @ $13.52 · Option exercise (M): 55,226 · Sale (S): 26,053 @ $13.52 · Option exercise (M): 22,576 (derivative) @ $0 · Option exercise (M): 55,226 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 62,250 · Sale (S): 62,250 @ $13.34 · Option exercise (M): 33,512 · Sale (S): 33,512 @ $13.34 · Option exercise (M): 62,250 (derivative) @ $0 · Option exercise (M): 33,512 (derivative) @ $0 · +1 more | EDGAR |
| 2024-03-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,599 · Sale (S): 20,599 @ $13.12 · Option exercise (M): 20,599 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 55,226 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 18,002 @ $9.93 · Sale (S): 54,007 @ $9.43 | EDGAR |
| 2023-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 15,921 · Option exercise (M): 33,512 · Option exercise (M): 22,576 · Grant/award (A): 249,003 (derivative) @ $0 · Option exercise (M): 15,921 (derivative) @ $0 · Option exercise (M): 33,512 (derivative) @ $0 · +1 more | EDGAR |
| 2023-03-02 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,598 · Sale (S): 20,598 @ $9.89 · Option exercise (M): 50,242 · Sale (S): 23,654 @ $9.89 · Option exercise (M): 20,598 (derivative) @ $0 · Option exercise (M): 50,242 (derivative) @ $0 | EDGAR |
| 2023-02-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 50,242 (derivative) @ $0 | EDGAR |
| 2022-03-08 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 15,920 · Sale (S): 15,920 @ $7.48 · Option exercise (M): 43,358 · Sale (S): 20,456 @ $7.48 · Option exercise (M): 22,576 · Sale (S): 22,576 @ $7.37 · +4 more | EDGAR |
| 2022-03-02 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,598 · Sale (S): 20,598 @ $8.14 · Option exercise (M): 20,598 (derivative) @ $0 | EDGAR |
| 2022-02-10 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 13,135 · Sale (S): 13,135 @ $9.06 · Option exercise (M): 13,135 (derivative) @ $0 · Grant/award (A): 43,358 (derivative) @ $0 | EDGAR |
| 2021-03-08 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 15,920 · Sale (S): 7,513 @ $10.58 · Option exercise (M): 15,920 (derivative) @ $0 · Grant/award (A): 90,304 (derivative) @ $0 | EDGAR |
| 2021-03-04 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 2,101 · Sale (S): 993 @ $10.88 · Option exercise (M): 2,101 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,598 · Sale (S): 20,598 @ $10.85 · Option exercise (M): 20,598 (derivative) @ $0 | EDGAR |
| 2021-02-11 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 13,135 · Grant/award (A): 55,287 · Sale (S): 13,135 @ $12.72 · Sale (S): 55,287 @ $12.72 · Option exercise (M): 13,135 (derivative) @ $0 | EDGAR |
| 2020-09-10 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 698 · Sale (S): 333 @ $8.98 · Option exercise (M): 698 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1726096 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs